Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Mark Hallett MD
Mark Hallett MD Editor-in-Chief
Avindra Nath MD
Avindra Nath MD Associate Editor
Marinos Dalakas MD, FAAN
Marinos C. Dalakas MD, FAAN Advisory Board
See All Experts
Published in Neurology

News · July 09, 2024

EAN 2024: Both Galcanezumab, Prednisone Cut Headache Frequency With Medication Overuse Headaches

However, use of prednisone tied to significantly higher rate of adverse events

PracticeUpdate Editorial Team

 

 Save  Recommend
 Share

Further Reading

Most Read This Week

Recently Updated